https://www.selleckchem.com/pr....oducts/dibutyryl-cam
4%), and infection, occurring in 5 (0.3%). Four different arthroplasty brands were used in this cohort, with the Delta Xtend in two-thirds of cases (n = 1025). Age younger than 60 years and male sex were associated with slightly higher rates of revision; however, these differences did not reach statistical significance (hazard ratio of 2.02 with P = .075 and hazard ratio of 3.23 with P = .057, respectively). Conclusion The use of RSA for acute PHFs is increasing in the Nordic countries. The short-term risk of revision
Like
Comment
Share
